Given that GRK6 knockout mice are viable, and prominent growth arrest of lymphoid leukemia cell line was observed upon GRK6 knockdown, it might be feasible that GRK6 be used as a potential target for treatment of leukemia. Here, GRK6 is linked to lymphoid leukemia.